Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
Department of Clinical Trial Planning and Management, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
World J Surg. 2021 Aug;45(8):2492-2500. doi: 10.1007/s00268-021-06148-7. Epub 2021 May 3.
Chronic obstructive pulmonary disease (COPD) is known to be a risk factor of pneumonia after esophagectomy. In this study, we investigated the relationship of airflow limitation with the occurrence and the severity of pneumonia in esophageal cancer patients who underwent esophagectomy.
We enrolled 844 patients who underwent curative esophagectomy between 2009 and 2018. The airflow limitation was evaluated using the percent-predicted forced expiratory volume at 1 s (%FEV1) with spirometry.
There were 597 (70.7%), 141 (16.7%), 68 (8.1%), and 38 patients (4.5%) with %FEV1 of ≥ 90%, 80-90%, 70-80%, and < 70% categories, respectively. One hundred and ninety-one patients (22.6%) occurred pneumonia, and the incidences of pneumonia in each category of patients were 18.8%, 28.4%, 29.4%, and 50.0%, respectively. In multivariate analysis, the categories of 80%-90%, 70-80%, and < 70% were significantly associated with a higher incidence of postoperative pneumonia (OR 1.57; 95% CI 1.02-2.43, OR 1.87; 95% CI 1.04-3.36, OR 3.34; 95% CI 1.66-6.71, respectively), with the %FEV1 category of ≥ 90% as reference. The incidence of severe pneumonia of Clavien-Dindo grade III or higher was also significantly associated with the %FEV1. In patients without COPD, the incidence of pneumonia was significantly higher in those with %FEV1 < 90% than in those with %FEV1 ≥ 90% (32.2% versus 17.5%, p < 0.001).
The airflow limitation can help predict the occurrence of pneumonia after esophagectomy in patients with and without COPD. Exclusive preventive measures should be considered in patients with reduced %FEV1 undergoing esophagectomy.
慢性阻塞性肺疾病(COPD)已知是食管癌手术后肺炎的危险因素。在这项研究中,我们研究了气流受限与接受食管癌切除术的食管癌患者肺炎的发生和严重程度的关系。
我们纳入了 2009 年至 2018 年间接受根治性食管癌切除术的 844 例患者。使用肺活量计评估用力呼气量占预计值的百分比(%FEV1)来评估气流受限。
分别有 597(70.7%)、141(16.7%)、68(8.1%)和 38 例(4.5%)患者的 %FEV1≥90%、80-90%、70-80%和<70%。191 例(22.6%)患者发生肺炎,各患者组的肺炎发生率分别为 18.8%、28.4%、29.4%和 50.0%。多因素分析显示,80-90%、70-80%和<70%组与术后肺炎发生率较高显著相关(OR 1.57;95%CI 1.02-2.43,OR 1.87;95%CI 1.04-3.36,OR 3.34;95%CI 1.66-6.71,分别),以 %FEV1≥90%为参考。无 COPD 患者中,%FEV1<90%的患者肺炎发生率明显高于%FEV1≥90%的患者(32.2%比 17.5%,p<0.001)。
气流受限可帮助预测 COPD 患者和非 COPD 患者食管癌术后肺炎的发生。对于接受食管癌切除术的 %FEV1 降低的患者,应考虑采取专门的预防措施。